{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/03bfeb35-6051-497a-abc3-bd7d7f415e15/5e5b7ac3-5b52-44f0-9dea-f42334f768a6?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"US versus EU science reporting","description":"In this week's podcast: we talk to vice-president of the Association of Healthcare Journalists and science editor of the Philadelphia Inquirer, Karl Stark, about the state of health/science journalism in the US and in Europe and we hear from AAAS about new enzymes linked to a cancer-related muscle wasting disorder called cachexia.\r\n\r\nPresented by Clive Cookson with Andrew Jack and Diana Garnham\r\n\r\nProduced by LJ Filotrani","author_name":"Financial Times"}